Scientific Advisory Committee on Oncology Therapies (SAC-OT) : Agenda

Location: 1600 Scott Street, Holland Cross, Tower B, Room 2048
Date & time: June 14, 2019, 8:30 AM - 4:15 PM
Participants: SAC-OT members, guest speakers, Health Canada employees

8:00-8:30
Refreshments

8:30-9:00
Opening Remarks
Melissa Hunt (Director, Bureau of Metabolism, Oncology and Reproductive Sciences, Therapeutic Products Directorate; TPD)
Review of the Agenda, Declaration of Affiliations and Interests
Dr. Alexander H.G. Paterson (Chair)

9:00-9:30
Tumor-Agnostic Cancer Treatment (TACT) Definitions
Precision/Personalized Oncology: Clinician's Perspective
Presenter: Dr. Gwyn Bebb
Precision Oncology: Researcher's Perspective
Presenter: Dr. Steve Robbins

9:30-10:00
TACT: Current Pre-Market Regulatory Landscape
Presenters: TPD, Biologics and Genetic Therapies Directorate (BGTD)

10:00-10:30
TACT: Post-market Considerations
Presenter: Marketed Health Products Directorate (MHPD)

10:30-10:45
Break

10:45-11:15
Canadian Clinical Context
Presenter: Dr. Gwyn Bebb

11:15-12:00
Deliberations
SAC-OT members

12:00-13:00
Lunch

13:00-16:00
Deliberations
SAC-OT members

16:00-16:15
Next Steps, Closing Remarks and Adjournment of Meeting
Dr. Alexander H.G. Paterson (Chair)